Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergen immunotherapy: present and future.

Ira Finegold1

  • 1Institute of Allergy, St. Luke's-Roosevelt Hospital, New York, New York 10022, USA. drfinegold@aol.com

Allergy and Asthma Proceedings
|March 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A brief history of allergen immunotherapy.

Allergy and asthma proceedings·2022
Same author

The American College of Allergy, Asthma & Immunology: An 80-year legacy of accomplishments (1942-2022), part 3: Events and achievements (2012-2022).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2022
Same author

Rhinitis 2020: A practice parameter update.

The Journal of allergy and clinical immunology·2020
Same author

Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2017
Same author

The management of paediatric allergy: not everybody's cup of tea--10-11th February 2012.

Current opinion in allergy and clinical immunology·2013
Same author

Food and Drug Administration reclassification of allergens for diagnosis and treatment: now is the time to be heard.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2012
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Immunotherapy effectively modifies allergic disease by reducing inflammation and preventing new sensitivities. This treatment offers lasting benefits for allergic rhinitis and asthma, potentially surpassing pharmacotherapy alone.

Area of Science:

  • Allergy and Immunology
  • Immunotherapy Mechanisms
  • Clinical Efficacy

Background:

  • Allergic diseases significantly impact quality of life.
  • Current pharmacotherapy for asthma often fails to achieve complete control.
  • Immunotherapy presents a disease-modifying approach to allergic conditions.

Purpose of the Study:

  • To review the current understanding of immunotherapy mechanisms.
  • To assess the clinical efficacy of immunotherapy.
  • To discuss future directions and challenges in immunotherapy.

Main Methods:

  • Review of existing literature on immunotherapy.
  • Analysis of mechanisms driving immunotherapy's effects.
  • Evaluation of clinical trial data on immunotherapy outcomes.

Related Experiment Videos

Main Results:

  • Immunotherapy demonstrably alters the natural course of allergic disease.
  • Key effects include reduced inflammation, decreased hyperresponsiveness, and prevention of new allergies.
  • Efficacy persists post-treatment, and immunotherapy may be crucial for achieving asthma control goals.

Conclusions:

  • Immunotherapy is a well-understood treatment that modifies allergic disease progression.
  • Subcutaneous immunotherapy is the preferred allergen-specific treatment in the US.
  • Further advancements and challenges are anticipated, but immunotherapy holds significant promise for allergic conditions.